Ypera Inc.
One devoted
Scientific Family
Improving your Life
through Science
Company
Management
Cord T. Nieberg
"Our mission is to develop biocologic and nutrakinetic health products that can sustain, restore and improve the quality of human life by helping people to do more, feel better, and live longer."
Our Milestones
2014
2015
2016
2017
2018
Commercial development of YPERA® Gel Packets, an innovative QoL Enhancer™ supplement, manufactured in the USA in compliance with NFS and GMP standards.
-
2014
Scientific research on nutrient deficiencies caused by Oxidative Stress and common related alignments incl. Cancer and ALS as well as premature aging due to immune imbalances and the degradation of DNA. -
2015
Formation of strategic collaborations and the development of effective preliminary scientific formulations and initial prototypes of non-drug based nutraceuticals and health supplements. -
2016
Promising In Vivo studies in which the immune and performance-enhancing effects of the formulations were tested, on the whole, living organisms and cells, including plants, humans, and selected animals. -
2017
Establishment of Ypera Inc. in Los Angeles, CA and Ypera LifeSciences™ in Miami, FL and initiation of the commercial development of product pipeline in line with FDA regulations. -
2018
Commercial development of YPERA® Gel Packets, an innovative QoL Enhancer™ supplement, manufactured in the USA in compliance with NFS and GMP standards.
We Are Proud to Present You Our Achievements in 2019.
2019 has been a successful year for Ypera Inc. and Ypera Lifesciences™. We have reserved the rights to "YPERA" as a US trademark with the USPTO. We have completed the commercial development and initiated production of Ypera®, our first specialized supplement to be manufactured in the US in line with NFS and GMP standards. We've successfully acquired the exclusive domain ypera.com. We have established new relations and partnerships in three international markets, including the Dubai, Liechtenstein, and the UK. Developing distribution deals worth over 12k units of YPERA®, and we currently have three new products in the late commercial development phase for launch in Q3-Q4 in 2020.
®
3
12K
30
Over the Next Few Years We Will Be Pursuing More Ambitious Goals
From 2020 through 2025, we will launch (30) new bio-scientific products for health and wellness applications and focus on the establishment of selected ventures in line with our overall mission and vision. We will continue with a clinical development plan for TUTAMIN™, a biological combination of proteins. The primary goal is to obtain regulatory approval for TUTAMIN™ as soon as possible, based on compelling studies and medical data, and to expand TUTAMIN™ commercially Valuable new treatment areas, including immunotherapy and immunomodulatory drugs (IMiD) in collaboration with pharmaceutical partners.
Contact
If you're calling from outside the USA and or are looking for a specific department, please follow our Contact Directory page.
Office
201 S Biscayne Blvd, 28Floor
Miami, FL 33131
U.S.A.
Social
You can contact us directly with a direct message (DM) on our global Ypera Facebook page.
Product
Company
Learn & Support
